Retatrutide and Weight Management: Clinical Efficacy, Reported Benefits, Safety Signals, and Uncertainty Surrounding Unverified Products

This narrative literature review examines the clinical evidence on retatrutide for weight management, including reported efficacy, safety signals, and uncertainties surrounding unverified products marketed under its name. It summarizes available clinical trial findings and discusses reports involving products of uncertain composition. The review distinguishes evidence from clinical trials from reports involving unverified products and highlights the limitations of current evidence. Retatrutide remains investigational, and products sold outside authorized clinical research may not contain the ingredients claimed on their labels. This article is intended for educational purposes and does not replace professional medical advice.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-29
DOI
https://doi.org/10.5281/zenodo.23774140
Primary Topic
Pharmacology and Obesity Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Retatrutide and Weight Management: Clinical Efficacy, Reported Benefits, Safety Signals, and Uncertainty Surrounding Unverified Products

Rooney Haniti
1 links
Zenodo (CERN European Organization for Nuclear Research)
Pharmacology and Obesity Treatment
preprint

Retatrutide and Weight Management: Clinical Efficacy, Reported Benefits, Safety Signals, and Uncertainty Surrounding Unverified Products

Rooney Haniti
preprint en

Abstract

This narrative literature review examines the clinical evidence on retatrutide for weight management, including reported efficacy, safety signals, and uncertainties surrounding unverified products marketed under its name. It summarizes available clinical trial findings and discusses reports involving products of uncertain composition. The review distinguishes evidence from clinical trials from reports involving unverified products and highlights the limitations of current evidence. Retatrutide remains investigational, and products sold outside authorized clinical research may not contain the ingredients claimed on their labels. This article is intended for educational purposes and does not replace professional medical advice.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Pharmacology and Obesity Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon